Clinical Trial Update: Risk Stratification of Cancer Therapy-Related Cardiac Dysfunction Using AI-Enhanced Electrocardiography

View source ↗

Summary

Completed clinical trial evaluating AI-enhanced electrocardiography to risk-stratify cancer therapy-related cardiac dysfunction and related heart conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Therapy-related Cardiac Dysfunction
• Heart Failure
• Left Ventricular Dysfunction

Snippet

Sponsor: Yonsei University | Conditions: Cancer Therapy-Related Cardiac Dysfunction, Heart Failure | Status: COMPLETED